Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis. - Wikidata - awgldk - TriplyDB

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

http://www.wikidata.org/entity/Q33728414

about

Endochondral Ossification Is Accelerated in Cholinesterase-Deficient Mice and in Avian Mesenchymal Micromass Cultures.Effect of M3 muscarinic acetylcholine receptor deficiency on collagen antibody-induced arthritis.

P2860

Q36258689-0E7EB09C-26DD-404C-B65B-A679DC79F639 Q36480715-7A5B32BB-B389-417C-A102-5E14A777EB30

P2860

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

http://www.wikidata.org/entity/Q33728414

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@ast

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@en

type

label

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@ast

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@en

prefLabel

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@ast

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@en

P1433

Q33728414-FD66BF90-B862-4162-AC14-ED724823D0EE

P1476

Q33728414-F7B38084-9CA9-4141-88EC-4BDC5C602AF0

P2093

Q33728414-016AD0AC-43FF-4866-88A7-A9D20176BB7E

Q33728414-3986AAE0-E6CC-4774-A099-4B33F7921E8C

Q33728414-CF5485AB-B062-48AD-BCA0-A5B0D394A2F1

Q33728414-E69533DC-800A-4F17-8276-6EBDC484DCED

P2860

Q33728414-14C45A3F-585B-412C-B1D6-BF438EA06AF3

Q33728414-223FE18F-1941-4C2A-A629-145935A21C0F

Q33728414-31A8C397-BDCD-42A0-B279-E667C77E3C5D

Q33728414-4F8F37D0-012A-4075-86AD-76C2259AB135

Q33728414-61A86071-08E4-4110-A06C-57FCB6867600

Q33728414-69B29183-C895-42DB-878F-A494EB21BF42

Q33728414-7410963C-1BB1-4CA8-B47A-01550F060621

Q33728414-77B0CBA8-0B78-46AF-ADBB-1399AF58D78E

Q33728414-91EE5EDA-433B-44FD-A3A4-D6336838743D

Q33728414-951BD4E3-4347-4366-BDA0-7ADE851BD40D

P304

Q33728414-D12B7B09-9263-43D4-BF30-5C41D7982E57

P31

Q33728414-2485CD85-A743-4E70-AA01-1366BE61F235

P356

Q33728414-C659046B-3B0E-4ADF-AEC2-62B19DC0D80A

P478

Q33728414-128A2707-5DD7-483E-89B9-024C57820B19

P577

Q33728414-AABD4B0A-6987-46C8-8784-15650ACFA90D

P5875

Q33728414-B4BDBF5A-B5FC-4851-9757-0A693E78FB7D

P698

Q33728414-BBCB9D6B-CE1B-43D6-9277-730E594695A6

P932

Q33728414-7523C522-CF1E-49EA-A345-A3B5771C658C

P356

P1433

Medical Science Monitor

P1476

Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis.

@en

P2093

Christian Heiss

http://www.w3.org/2001/XMLSchema#string

Katrin Susanne Lips

http://www.w3.org/2001/XMLSchema#string

Reinhard Schnettler

http://www.w3.org/2001/XMLSchema#string

Vivien Kauschke

http://www.w3.org/2001/XMLSchema#string

P2860

Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.

Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity.

Oestrogen and the cholinergic hypothesis: implications for oestrogen replacement therapy in postmenopausal women.

Osteoporosis and gastrointestinal disease.

Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXA.

Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.

[Ovariectomy and calcium/vitamin D2/D3 deficient diet as a model of osteoporosis in the spine of Sprague-Dawley rats].

Experimental osteoporosis induced by ovariectomy and vitamin D deficiency does not markedly affect fracture healing in rats.

The ovariectomized rat model of postmenopausal bone loss.

Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.

P304

869-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.890217

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262683114

http://www.w3.org/2001/XMLSchema#string

P698

24866457

http://www.w3.org/2001/XMLSchema#string

P932

4049973

http://www.w3.org/2001/XMLSchema#string